SCHEMBL7813352

SCHEMBL7813352

C=CCC1(C2=CCN(Cc3ccccc3)CC2)c2ccccc2CCc2ccccc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 10/20 0.44
TP53 P04637 2/20 0.44
CYP1A2 P05177 2/20 0.44
CYP3A4 P08684 2/20 0.44
CYP2D6 P10635 2/20 0.44
TSHR P16473 2/20 0.44
CYP2C19 P33261 2/20 0.44
ALDH1A1 P00352 1/20 0.44
CYP2C9 P11712 1/20 0.44
DRD2 P14416 5/20 0.43
HTR2A P28223 2/20 0.43
NFKB1 P19838 1/20 0.43
HTR2C P28335 1/20 0.43
MAPK1 P28482 1/20 0.43
HTR2B P41595 1/20 0.43
MTOR P42345 1/20 0.43
MEN1 O00255 1/20 0.42
BLM P54132 1/20 0.42
PMP22 Q01453 1/20 0.42
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7809704 0.81 MAPK1 (0.38) SIGMAR1DRD2MAPK1KMT2ADRD4
SCHEMBL7817126 0.76 NOTUM (0.40) SIGMAR1MAPK1MEN1KMT2A
SCHEMBL7804295 0.70 HTR2A (0.37) SIGMAR1HTR2AHTR2CMEN1
Iodide SCHEMBL7813387 0.68 SIGMAR1 (0.31) SIGMAR1
SCHEMBL1076822 0.66 SIGMAR1 (0.53) SIGMAR1DRD2HTR2ANAMPTHTR1A
SCHEMBL7867627 0.66 SIGMAR1 (0.42) SIGMAR1DRD2HTR2AHTR1AHTT
SCHEMBL8542310 0.66 DRD2 (0.43) SIGMAR1DRD2HTR2AHTR1AHTT
SCHEMBL831288 0.65 CYP3A4 (0.53) SIGMAR1TP53CYP1A2CYP3A4CYP2D6
SCHEMBL12798134 0.65 SIGMAR1 (0.55) SIGMAR1DRD2HTR2ANAMPTHTR1A
SCHEMBL29760370 0.64 SIGMAR1 (0.55) SIGMAR1TP53CYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0733043-B1 TRICYCLIC DERIVATIVES AND THEIR USE IN PHARMACEUTICALS SCHERING CORP (US) 2001-06-20 EP disclosed
US-5464840-A Pharmaceuticals to inhibit tumor necrosis factor-alpha and to treat septic shock, inflammation and allergic disease SCHERING CORPORATION (US) 1995-11-07 US disclosed
WO-1995015949-A1 TRICYCLIC DERIVATIVES AND THEIR USE IN PHARMACEUTICALS SCHERING CORPORATION (US) 1995-06-15 WO disclosed